Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen N Davis

Showing results (41-50 of 127) with videos related to

Pageof 13
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|February 3, 2015
Ipragliflozin , a sodium-glucose cotransporter 2 inhibitor, in the treatment of type 2 diabetesMaka S Hedrington, Stephen N Davis
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|November 7, 2002
Hypoglycemia associated autonomic failureLaura Diedrich, Darleen Sandoval, Stephen N Davis
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 10, 2011
Clinical impact of initiating insulin glargine therapy with disposable pen versus vial in patients with type 2 diabetes mellitus in a managed care settingStephen N Davis, Wenhui Wei, Satish Garg
Pediatric Diabetes|June 5, 2009
Physical activity in adolescents with type 1 diabetes: is more better for glycemic control?Lisa Younk, Donna Tate, Stephen N Davis
Diabetes Technology & Therapeutics|June 15, 2011
Basal insulin treatment in type 2 diabetesMaka S Hedrington, Lindsay Pulliam, Stephen N Davis
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 4, 2025
Treatment of diabetes in patients with advanced chronic kidney disease or kidney failureGeorge Bonifant, Stephen N Davis, Matthew R Weir
The Journal of Family Practice|October 8, 2004
Optimizing combination therapy for type 2 diabetes in adolescents and adults: a case-based approachTom A Elasy, Philip Levy, Stephen N Davis
Diabetes Care|May 27, 2003
Hypoglycemia in diabetesPhilip E Cryer, Stephen N Davis, Harry Shamoon
Expert Opinion on Investigational Drugs|December 7, 2024
Drugs stimulating insulin secretion in early clinical development for the treatment of type 1 diabetes: what's new?Xinyuan Ning, Kashif M Munir, Stephen N Davis
Metabolism: Clinical and Experimental|November 14, 2007
Forebrain and hindbrain effects of ethanol on counterregulatory responses to hypoglycemia in conscious ratsDarleen A Sandoval, Bin Gong, Stephen N Davis
Pageof 13

Showing results (41-50 of 127) with videos related to

Sort By:
Pageof 13
Expert Opinion on Drug Metabolism & Toxicology|February 3, 2015
Ipragliflozin , a sodium-glucose cotransporter 2 inhibitor, in the treatment of type 2 diabetesMaka S Hedrington, Stephen N Davis
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|November 7, 2002
Hypoglycemia associated autonomic failureLaura Diedrich, Darleen Sandoval, Stephen N Davis
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 10, 2011
Clinical impact of initiating insulin glargine therapy with disposable pen versus vial in patients with type 2 diabetes mellitus in a managed care settingStephen N Davis, Wenhui Wei, Satish Garg
Pediatric Diabetes|June 5, 2009
Physical activity in adolescents with type 1 diabetes: is more better for glycemic control?Lisa Younk, Donna Tate, Stephen N Davis
Diabetes Technology & Therapeutics|June 15, 2011
Basal insulin treatment in type 2 diabetesMaka S Hedrington, Lindsay Pulliam, Stephen N Davis
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 4, 2025
Treatment of diabetes in patients with advanced chronic kidney disease or kidney failureGeorge Bonifant, Stephen N Davis, Matthew R Weir
The Journal of Family Practice|October 8, 2004
Optimizing combination therapy for type 2 diabetes in adolescents and adults: a case-based approachTom A Elasy, Philip Levy, Stephen N Davis
Diabetes Care|May 27, 2003
Hypoglycemia in diabetesPhilip E Cryer, Stephen N Davis, Harry Shamoon
Expert Opinion on Investigational Drugs|December 7, 2024
Drugs stimulating insulin secretion in early clinical development for the treatment of type 1 diabetes: what's new?Xinyuan Ning, Kashif M Munir, Stephen N Davis
Metabolism: Clinical and Experimental|November 14, 2007
Forebrain and hindbrain effects of ethanol on counterregulatory responses to hypoglycemia in conscious ratsDarleen A Sandoval, Bin Gong, Stephen N Davis
Pageof 13